Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis
Isabel Aguilera, José Manuel Sousa, Francisco Gavilan, Lourdes Gomez, Antonia Álvarez‐Márquez, Antonio Núñez‐Roldán – 21 March 2011 – De novo immune hepatitis (DNIH) is a form of late graft dysfunction after liver transplantation. The fine mechanisms leading to the development of DNIH are not known, and whether this hepatitis is a form of rejection or a result of an auto/alloimmune injury has not been established.